Use of cytotoxic drugs in dermatologic diseases. II.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003240:Connective Tissue Diseases / Q000188:drug therapy; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007165:Immunosuppression Therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012507:Sarcoidosis / Q000188:drug therapy; D012598:Sclerosis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy; D014657:Vasculitis / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy
D000970:Antineoplastic Agents